Literature DB >> 18201677

Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Christine E McLaren1, Victor R Gordeuk, Wen-Pin Chen, James C Barton, Ronald T Acton, Mark Speechley, Oswaldo Castro, Paul C Adams, Beverly M Snively, Emily L Harris, David M Reboussin, Geoffrey J McLachlan, Richard Bean.   

Abstract

Bivariate mixture modeling was used to analyze joint population distributions of transferrin saturation (TS) and serum ferritin concentration (SF) measured in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Four components (C1, C2, C3, and C4) with successively age-adjusted increasing means for TS and SF were identified in data from 26,832 African Americans, 12,620 Asians, 12,264 Hispanics, and 43,254 whites. The largest component, C2, had normal mean TS (21% to 26% for women, 29% to 30% for men) and SF (43-82 microg/L for women, 165-242 microg/L for men), which consisted of component proportions greater than 0.59 for women and greater than 0.68 for men. C3 and C4 had progressively greater mean values for TS and SF with progressively lesser component proportions. C1 had mean TS values less than 16% for women (<20% for men) and SF values less than 28 microg/L for women (<47 microg/L for men). Compared with C2, adjusted odds of iron deficiency were significantly greater in C1 (14.9-47.5 for women, 60.6-3530 for men), adjusted odds of liver disease were significantly greater in C3 and C4 for African-American women and all men, and adjusted odds of any HFE mutation were increased in C3 (1.4-1.8 for women, 1.2-1.9 for men) and in C4 for Hispanic and white women (1.5 and 5.2, respectively) and men (2.8 and 4.7, respectively). Joint mixture modeling identifies a component with lesser SF and TS at risk for iron deficiency and 2 components with greater SF and TS at risk for liver disease or HFE mutations. This approach can identify populations in which hereditary or acquired factors influence metabolism measurement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18201677      PMCID: PMC3785302          DOI: 10.1016/j.trsl.2007.10.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  22 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Measurements of iron status in patients with chronic hepatitis.

Authors:  A M Di Bisceglie; C A Axiotis; J H Hoofnagle; B R Bacon
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

3.  The diversity of liver diseases among outpatient referrals for an elevated serum ferritin.

Authors:  Karen Wong; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2006-07       Impact factor: 3.522

4.  Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis.

Authors:  C E McLaren; G J McLachlan; J W Halliday; S I Webb; B A Leggett; E C Jazwinska; D H Crawford; V R Gordeuk; G D McLaren; L W Powell
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

5.  Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.

Authors:  Christine E McLaren; Kuo-Tung Li; Gordon D McLaren; Victor R Gordeuk; Beverly M Snively; David M Reboussin; James C Barton; Ronald T Acton; Fitzroy W Dawkins; Emily L Harris; John H Eckfeldt; Godfrey C Moses; Paul C Adams
Journal:  Transl Res       Date:  2006-10       Impact factor: 7.012

6.  Iron deficiency anemia: higher prevalence in Mexican American than in non-Hispanic white females in the third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  A L Frith-Terhune; M E Cogswell; L K Khan; J C Will; U Ramakrishnan
Journal:  Am J Clin Nutr       Date:  2000-10       Impact factor: 7.045

7.  Hyperferremia in immunosuppressed patients with acute nonlymphocytic leukemia and the risk of infection.

Authors:  V R Gordeuk; G M Brittenham; G D McLaren; P J Spagnuolo
Journal:  J Lab Clin Med       Date:  1986-11

8.  Study of the genetic transmission of hypercholesterolemia and hypertriglyceridemia in a 195 member kindred.

Authors:  R C Elston; K K Namboodiri; C J Glueck; R Fallat; R Tsang; V Leuba
Journal:  Ann Hum Genet       Date:  1975-07       Impact factor: 1.670

9.  A nomogram to predict C282Y hemochromatosis.

Authors:  Jerry S McGrath; Yves Deugnier; Romain Moirand; Anne-Marie Jouanolle; Subrata Chakrabarti; Paul C Adams
Journal:  J Lab Clin Med       Date:  2002-07

Review 10.  Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes.

Authors:  C Q Edwards; L M Griffen; J Kaplan; J P Kushner
Journal:  J Intern Med       Date:  1989-11       Impact factor: 8.989

View more
  2 in total

1.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Gordon D McLaren; Victor R Gordeuk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

2.  Bivariate mixture models for the joint distribution of repeated serum ferritin and transferrin saturation measured 12 years apart in a cohort of healthy middle-aged Australians.

Authors:  Christine E McLaren; Wen-Pin Chen; Nadine A Bertalli; Martin B Delatycki; Graham G Giles; Dallas R English; John L Hopper; Katrina J Allen; Lyle C Gurrin
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.